These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33880467)

  • 1. Clinicopathologic features of a feline SARS-CoV-2 infection model parallel acute COVID-19 in humans.
    Rudd JM; Selvan MT; Cowan S; Kao YF; Midkiff CC; Ritchey JW; Miller CA
    bioRxiv; 2021 Apr; ():. PubMed ID: 33880467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Histopathologic Features of a Feline SARS-CoV-2 Infection Model Are Analogous to Acute COVID-19 in Humans.
    Rudd JM; Tamil Selvan M; Cowan S; Kao YF; Midkiff CC; Narayanan S; Ramachandran A; Ritchey JW; Miller CA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS CoV-2 (Delta Variant) Infection Kinetics and Immunopathogenesis in Domestic Cats.
    Tamil Selvan M; Gunasekara S; Xiao P; Griffin K; Cowan SR; Narayanan S; Ramachandran A; Hagen DE; Ritchey JW; Rudd JM; Miller CA
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilizing Feline Lentiviral Infection to Establish a Translational Model for COVID-19 in People with Human Immunodeficiency Virus Infection.
    Shatnawi S; Gunasekara S; Bashor L; Tamil Selvan M; Nehring M; Cowan S; Ritchey J; VandeWoude S; Taylor B; Miller C; Rudd JM
    Microorganisms; 2024 Jun; 12(7):. PubMed ID: 39065058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of whole body glucose metabolism in a feline SARS-CoV-2 infection model.
    Rochowski MT; Jayathilake K; Balcerak JM; Tamil Selvan M; Gunasekara S; Rudd J; Miller C; Lacombe VA
    Am J Physiol Regul Integr Comp Physiol; 2024 Jun; 326(6):R499-R506. PubMed ID: 38574344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 Infection.
    Krüger N; Rocha C; Runft S; Krüger J; Färber I; Armando F; Leitzen E; Brogden G; Gerold G; Pöhlmann S; Hoffmann M; Baumgärtner W
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthropogenic Infection of Cats during the 2020 COVID-19 Pandemic.
    Hosie MJ; Hofmann-Lehmann R; Hartmann K; Egberink H; Truyen U; Addie DD; Belák S; Boucraut-Baralon C; Frymus T; Lloret A; Lutz H; Marsilio F; Pennisi MG; Tasker S; Thiry E; Möstl K
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33530620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
    Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
    mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CHARTER-Ireland trial: can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trial.
    Sheehan JR; Calpin P; Kernan M; Kelly C; Casey S; Murphy D; Alvarez-Iglesias A; Giacomini C; Cody C; Curley G; McGeary S; Hanley C; McNicholas B; van Haren F; Laffey JG; Cosgrave D
    Trials; 2022 Sep; 23(1):774. PubMed ID: 36104785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19.
    Tiwari S; Goel G; Kumar A
    Int Rev Immunol; 2024; 43(1):13-32. PubMed ID: 35757923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients.
    Wang C; Xie J; Zhao L; Fei X; Zhang H; Tan Y; Nie X; Zhou L; Liu Z; Ren Y; Yuan L; Zhang Y; Zhang J; Liang L; Chen X; Liu X; Wang P; Han X; Weng X; Chen Y; Yu T; Zhang X; Cai J; Chen R; Shi ZL; Bian XW
    EBioMedicine; 2020 Jul; 57():102833. PubMed ID: 32574956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology of experimental SARS coronavirus infection in cats and ferrets.
    van den Brand JM; Haagmans BL; Leijten L; van Riel D; Martina BE; Osterhaus AD; Kuiken T
    Vet Pathol; 2008 Jul; 45(4):551-62. PubMed ID: 18587105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Responses and Pathogenesis following Experimental SARS-CoV-2 Infection in Domestic Cats.
    Vreman S; van der Heijden EMDL; Ravesloot L; Ludwig IS; van den Brand JMA; Harders F; Kampfraath AA; Egberink HF; Gonzales JL; Oreshkova N; Broere F; van der Poel WHM; Gerhards NM
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model.
    Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher PS; Villano JS; Littlefield K; Ruelas Castillo J; Marinho P; Jedlicka AE; Ordonez AA; Bahr M; Majewska N; Betenbaugh MJ; Flavahan K; Mueller ARL; Looney MM; Quijada D; Mota F; Beck SE; Brockhurst J; Braxton AM; Castell N; Stover M; D'Alessio FR; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL;
    mBio; 2021 Aug; 12(4):e0097421. PubMed ID: 34253053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe SARS-CoV-2 Infection in a Cat with Hypertrophic Cardiomyopathy.
    Carvallo FR; Martins M; Joshi LR; Caserta LC; Mitchell PK; Cecere T; Hancock S; Goodrich EL; Murphy J; Diel DG
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS-CoV-2 infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    bioRxiv; 2022 Jun; ():. PubMed ID: 35734088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.